Literature DB >> 20119830

Deficits of long-term memory in ecstasy users are related to cognitive complexity of the task.

John Brown1, Elinor McKone, Jeff Ward.   

Abstract

RATIONALE: Despite animal evidence that methylenedioxymethamphetamine (ecstasy) causes lasting damage in brain regions related to long-term memory, results regarding human memory performance have been variable. This variability may reflect the cognitive complexity of the memory tasks. However, previous studies have tested only a limited range of cognitive complexity. Furthermore, comparisons across different studies are made difficult by regional variations in ecstasy composition and patterns of use.
OBJECTIVES: The objective of this study is to evaluate ecstasy-related deficits in human verbal memory over a wide range of cognitive complexity using subjects drawn from a single geographical population.
MATERIALS AND METHODS: Ecstasy users were compared to non-drug using controls on verbal tasks with low cognitive complexity (stem completion), moderate cognitive complexity (stem-cued recall and word list learning) and high cognitive complexity (California Verbal Learning Test, Verbal Paired Associates and a novel Verbal Triplet Associates test). Where significant differences were found, both groups were also compared to cannabis users.
RESULTS: More cognitively complex memory tasks were associated with clearer ecstasy-related deficits than low complexity tasks. In the most cognitively demanding task, ecstasy-related deficits remained even after multiple learning opportunities, whereas the performance of cannabis users approached that of non-drug using controls. Ecstasy users also had weaker deliberate strategy use than both non-drug and cannabis controls.
CONCLUSIONS: Results were consistent with the proposal that ecstasy-related memory deficits are more reliable on tasks with greater cognitive complexity. This could arise either because such tasks require a greater contribution from the frontal lobe or because they require greater interaction between multiple brain regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20119830     DOI: 10.1007/s00213-009-1766-2

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  68 in total

1.  Respondent-driven sampling to recruit MDMA users: a methodological assessment.

Authors:  Jichuan Wang; Robert G Carlson; Russel S Falck; Harvey A Siegal; Ahmmed Rahman; Linna Li
Journal:  Drug Alcohol Depend       Date:  2004-12-22       Impact factor: 4.492

Review 2.  Role of serotonin in memory impairment.

Authors:  M C Buhot; S Martin; L Segu
Journal:  Ann Med       Date:  2000-04       Impact factor: 4.709

3.  Reduced N-acetylaspartate levels in the frontal cortex of 3,4-methylenedioxymethamphetamine (Ecstasy) users: preliminary results.

Authors:  Liesbeth Reneman; Charles B L M Majoie; Herman Flick; Gerard J den Heeten
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

4.  Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.

Authors:  Una D McCann; Zsolt Szabo; Esen Seckin; Peter Rosenblatt; William B Mathews; Hayden T Ravert; Robert F Dannals; George A Ricaurte
Journal:  Neuropsychopharmacology       Date:  2005-09       Impact factor: 7.853

5.  Specific effects of ecstasy and other illicit drugs on cognition in poly-substance users.

Authors:  T Schilt; M M L de Win; G Jager; M W Koeter; N F Ramsey; B Schmand; W van den Brink
Journal:  Psychol Med       Date:  2007-11-08       Impact factor: 7.723

6.  Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.

Authors:  Jörg Daumann; Thomas Fischermann; Karsten Heekeren; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Journal:  Biol Psychiatry       Date:  2004-09-01       Impact factor: 13.382

7.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

Review 8.  Localization of cognitive operations in the human brain.

Authors:  M I Posner; S E Petersen; P T Fox; M E Raichle
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

9.  Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.

Authors:  R Thomasius; K Petersen; R Buchert; B Andresen; P Zapletalova; L Wartberg; B Nebeling; A Schmoldt
Journal:  Psychopharmacology (Berl)       Date:  2003-03-11       Impact factor: 4.530

10.  Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

Authors:  Ronald L Cowan; In Kyoon Lyoo; Seung Mo Sung; Kyung Heup Ahn; Minue J Kim; Jaeuk Hwang; Erika Haga; Ram Lakhan Panday Vimal; Scott E Lukas; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2003-12-11       Impact factor: 4.492

View more
  12 in total

1.  Prospective memory deficits in Ecstasy users: effects of longer ongoing task delay interval.

Authors:  Michael Weinborn; Steven Paul Woods; Claire Nulsen; Katherine Park
Journal:  J Clin Exp Neuropsychol       Date:  2011-11-03       Impact factor: 2.475

2.  Effects of ecstasy/polydrug use on memory for associative information.

Authors:  Denis T Gallagher; John E Fisk; Catharine Montgomery; Jeannie Judge; Sarita J Robinson; Paul J Taylor
Journal:  Psychopharmacology (Berl)       Date:  2012-08       Impact factor: 4.530

3.  Longer ongoing task delay intervals exacerbate prospective memory deficits in HIV-associated neurocognitive disorders (HAND).

Authors:  Erin E Morgan; Erica Weber; Alexandra S Rooney; Igor Grant; Steven Paul Woods
Journal:  J Clin Exp Neuropsychol       Date:  2012-02-02       Impact factor: 2.475

4.  Memory and brain volume in adults prenatally exposed to alcohol.

Authors:  Claire D Coles; Felicia C Goldstein; Mary Ellen Lynch; Xiangchuan Chen; Julie A Kable; Katrina C Johnson; Xiaoping Hu
Journal:  Brain Cogn       Date:  2010-11-09       Impact factor: 2.310

5.  Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.

Authors:  Robert W Gould; H Donald Gage; Matthew L Banks; Brandi L Blaylock; Paul W Czoty; Michael A Nader
Journal:  Neuropharmacology       Date:  2011-04-17       Impact factor: 5.250

6.  Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.

Authors:  Benjamin Becker; Daniel Wagner; Philip Koester; Katja Bender; Christoph Kabbasch; Euphrosyne Gouzoulis-Mayfrank; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2012-09-23       Impact factor: 4.530

7.  Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis.

Authors:  J Cobb Scott; Samantha T Slomiak; Jason D Jones; Adon F G Rosen; Tyler M Moore; Ruben C Gur
Journal:  JAMA Psychiatry       Date:  2018-06-01       Impact factor: 21.596

8.  The influence of genetic and environmental factors among MDMA users in cognitive performance.

Authors:  Elisabet Cuyàs; Antonio Verdejo-García; Ana Beatriz Fagundo; Olha Khymenets; Joan Rodríguez; Aida Cuenca; Susana de Sola Llopis; Klaus Langohr; Jordi Peña-Casanova; Marta Torrens; Rocío Martín-Santos; Magí Farré; Rafael de la Torre
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

9.  Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Scott F Martin; Berra Yazar-Klosinski; Yvonne Michel; Timothy D Brewerton; Rick Doblin
Journal:  J Psychopharmacol       Date:  2012-11-20       Impact factor: 4.153

Review 10.  3,4-methylenedioxymethamphetamine (MDMA): current perspectives.

Authors:  Jerrold S Meyer
Journal:  Subst Abuse Rehabil       Date:  2013-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.